|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/26 | (2006.01) |
| A61K 38/26 | (2013.01) | ||
| A61K 31/70 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61K 31/70 | (2013.01) | ||
| A61P 3/08 | (2018.01) | ||
| A61P 3/10 | (2018.01) |
| (11) | Number of the document | 3634468 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18730344.1 |
| Date of filing the European patent application | 2018-06-11 | |
| (97) | Date of publication of the European application | 2020-04-15 |
| (45) | Date of publication and mention of the grant of the patent | 2022-12-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2018/065266 |
| Date | 2018-06-11 |
| (87) | Number | WO 2018/224689 |
| Date | 2018-12-13 |
| (30) | Number | Date | Country code |
| 17175131 | 2017-06-09 | EP |
| (72) |
VEGGE, Andreas , DK
SCHÉELE, Susanne , DK
BJERREGAARD, Simon , DK
|
| (73) |
Novo Nordisk A/S ,
Novo Allé, 2880 Bagsværd,
DK
|
| (54) | SOLID COMPOSITIONS FOR ORAL ADMINISTRATION |
| SOLID COMPOSITIONS FOR ORAL ADMINISTRATION |